Treating Macular Degeneration
Macular degeneration affects about 8.5 million Americans over the age of 40. While the cause is unknown, the late stages of this condition can lead to blindness.
Geisinger’s eye specialists have wide-ranging expertise in diagnosing and treating macular degeneration. It affects the macula, or center, of the retina, which receives the images that translate into visual signals in our brain. When the tissue is damaged, we can lose our detailed central vision. Geisinger is one of only a few health systems in the area providing the new intravitreal eye injections that use an anti-VEGF (vascular endothelial growth factor) medication to help treat macular degeneration.
If you’re over 40, please be sure to have a Geisinger ophthalmology exam annually. This comprehensive evaluation can identify problems such as macular degeneration, which usually has no warning symptoms until the vision becomes impaired.
For consultations and referrals, call (570) 271-6531.
- Age-related Macular Degeneration (contributed by NEI) Features these videos:
Coping with Macular Degeneration
Living with Macular Degeneration